238 related articles for article (PubMed ID: 24368672)
1. Impact of insulin deprivation and treatment on sphingolipid distribution in different muscle subcellular compartments of streptozotocin-diabetic C57Bl/6 mice.
Zabielski P; Blachnio-Zabielska A; Lanza IR; Gopala S; Manjunatha S; Jakaitis DR; Persson XM; Gransee J; Klaus KA; Schimke JM; Jensen MD; Nair KS
Am J Physiol Endocrinol Metab; 2014 Mar; 306(5):E529-42. PubMed ID: 24368672
[TBL] [Abstract][Full Text] [Related]
2. Effect of a sustained reduction in plasma free fatty acid concentration on intramuscular long-chain fatty Acyl-CoAs and insulin action in type 2 diabetic patients.
Bajaj M; Suraamornkul S; Romanelli A; Cline GW; Mandarino LJ; Shulman GI; DeFronzo RA
Diabetes; 2005 Nov; 54(11):3148-53. PubMed ID: 16249438
[TBL] [Abstract][Full Text] [Related]
3. CerS1 but Not CerS5 Gene Silencing, Improves Insulin Sensitivity and Glucose Uptake in Skeletal Muscle.
Błachnio-Zabielska AU; Roszczyc-Owsiejczuk K; Imierska M; Pogodzińska K; Rogalski P; Daniluk J; Zabielski P
Cells; 2022 Jan; 11(2):. PubMed ID: 35053322
[TBL] [Abstract][Full Text] [Related]
4. Ceramide accumulation in L6 skeletal muscle cells due to increased activity of ceramide synthase isoforms has opposing effects on insulin action to those caused by palmitate treatment.
Frangioudakis G; Diakanastasis B; Liao BQ; Saville JT; Hoffman NJ; Mitchell TW; Schmitz-Peiffer C
Diabetologia; 2013 Dec; 56(12):2697-701. PubMed ID: 23989724
[TBL] [Abstract][Full Text] [Related]
5. Sphingolipids as a Culprit of Mitochondrial Dysfunction in Insulin Resistance and Type 2 Diabetes.
Roszczyc-Owsiejczuk K; Zabielski P
Front Endocrinol (Lausanne); 2021; 12():635175. PubMed ID: 33815291
[TBL] [Abstract][Full Text] [Related]
6. The Crucial Role of C18-Cer in Fat-Induced Skeletal Muscle Insulin Resistance.
Blachnio-Zabielska AU; Chacinska M; Vendelbo MH; Zabielski P
Cell Physiol Biochem; 2016; 40(5):1207-1220. PubMed ID: 27960149
[TBL] [Abstract][Full Text] [Related]
7. Skeletal muscle ceramides do not contribute to physical-inactivity-induced insulin resistance.
Appriou Z; Nay K; Pierre N; Saligaut D; Lefeuvre-Orfila L; Martin B; Cavey T; Ropert M; Loréal O; Rannou-Bekono F; Derbré F
Appl Physiol Nutr Metab; 2019 Nov; 44(11):1180-1188. PubMed ID: 30889368
[TBL] [Abstract][Full Text] [Related]
8. Astragalus polysaccharide improves insulin sensitivity in KKAy mice: regulation of PKB/GLUT4 signaling in skeletal muscle.
Liu M; Wu K; Mao X; Wu Y; Ouyang J
J Ethnopharmacol; 2010 Jan; 127(1):32-7. PubMed ID: 19800959
[TBL] [Abstract][Full Text] [Related]
9. Sphingolipid content of human adipose tissue: relationship to adiponectin and insulin resistance.
Blachnio-Zabielska AU; Koutsari C; Tchkonia T; Jensen MD
Obesity (Silver Spring); 2012 Dec; 20(12):2341-7. PubMed ID: 22677645
[TBL] [Abstract][Full Text] [Related]
10. Ceramides contained in LDL are elevated in type 2 diabetes and promote inflammation and skeletal muscle insulin resistance.
Boon J; Hoy AJ; Stark R; Brown RD; Meex RC; Henstridge DC; Schenk S; Meikle PJ; Horowitz JF; Kingwell BA; Bruce CR; Watt MJ
Diabetes; 2013 Feb; 62(2):401-10. PubMed ID: 23139352
[TBL] [Abstract][Full Text] [Related]
11. Ceramide content is increased in skeletal muscle from obese insulin-resistant humans.
Adams JM; Pratipanawatr T; Berria R; Wang E; DeFronzo RA; Sullards MC; Mandarino LJ
Diabetes; 2004 Jan; 53(1):25-31. PubMed ID: 14693694
[TBL] [Abstract][Full Text] [Related]
12. Pancreastatin inhibitor PSTi8 protects the obesity associated skeletal muscle insulin resistance in diet induced streptozotocin-treated diabetic mice.
Gupta AP; Garg R; Singh P; Goand UK; Syed AA; Valicherla GR; Riyazuddin M; Mugale MN; Gayen JR
Eur J Pharmacol; 2020 Aug; 881():173204. PubMed ID: 32439261
[TBL] [Abstract][Full Text] [Related]
13. CerS1-Derived C
Turpin-Nolan SM; Hammerschmidt P; Chen W; Jais A; Timper K; Awazawa M; Brodesser S; Brüning JC
Cell Rep; 2019 Jan; 26(1):1-10.e7. PubMed ID: 30605666
[TBL] [Abstract][Full Text] [Related]
14. Intracellular localization of diacylglycerols and sphingolipids influences insulin sensitivity and mitochondrial function in human skeletal muscle.
Perreault L; Newsom SA; Strauss A; Kerege A; Kahn DE; Harrison KA; Snell-Bergeon JK; Nemkov T; D'Alessandro A; Jackman MR; MacLean PS; Bergman BC
JCI Insight; 2018 Feb; 3(3):. PubMed ID: 29415895
[TBL] [Abstract][Full Text] [Related]
15. Sphingolipid changes do not underlie fatty acid-evoked GLUT4 insulin resistance nor inflammation signals in muscle cells.
Pillon NJ; Frendo-Cumbo S; Jacobson MR; Liu Z; Milligan PL; Hoang Bui H; Zierath JR; Bilan PJ; Brozinick JT; Klip A
J Lipid Res; 2018 Jul; 59(7):1148-1163. PubMed ID: 29794037
[TBL] [Abstract][Full Text] [Related]
16. Muscle sphingolipids during rest and exercise: a C18:0 signature for insulin resistance in humans.
Bergman BC; Brozinick JT; Strauss A; Bacon S; Kerege A; Bui HH; Sanders P; Siddall P; Wei T; Thomas MK; Kuo MS; Perreault L
Diabetologia; 2016 Apr; 59(4):785-98. PubMed ID: 26739815
[TBL] [Abstract][Full Text] [Related]
17. Central injection of GALR1 agonist M617 attenuates diabetic rat skeletal muscle insulin resistance through the Akt/AS160/GLUT4 pathway.
Fang P; Yu M; He B; Guo L; Huang X; Kong G; Shi M; Zhu Y; Bo P; Zhang Z
Mech Ageing Dev; 2017 Mar; 162():122-128. PubMed ID: 27041232
[TBL] [Abstract][Full Text] [Related]
18. Chronic Cannabidiol Administration Attenuates Skeletal Muscle De Novo Ceramide Synthesis Pathway and Related Metabolic Effects in a Rat Model of High-Fat Diet-Induced Obesity.
Bielawiec P; Harasim-Symbor E; Konstantynowicz-Nowicka K; Sztolsztener K; Chabowski A
Biomolecules; 2020 Aug; 10(9):. PubMed ID: 32859125
[TBL] [Abstract][Full Text] [Related]
19. Panax notoginseng saponins alleviate skeletal muscle insulin resistance by regulating the IRS1-PI3K-AKT signaling pathway and GLUT4 expression.
Guo X; Sun W; Luo G; Wu L; Xu G; Hou D; Hou Y; Guo X; Mu X; Qin L; Liu T
FEBS Open Bio; 2019 May; 9(5):1008-1019. PubMed ID: 30945455
[TBL] [Abstract][Full Text] [Related]
20. Effect of metformin on bioactive lipid metabolism in insulin-resistant muscle.
Zabielski P; Chacinska M; Charkiewicz K; Baranowski M; Gorski J; Blachnio-Zabielska AU
J Endocrinol; 2017 Jun; 233(3):329-340. PubMed ID: 28522731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
